PHIBRO ANIMAL HEALTH CORP-A (PAHC) Institutional Ownership Changes & 13F Activity

PHIBRO ANIMAL HEALTH CORP-A (PAHC) institutional ownership data tracks hedge funds, asset managers, and other institutional investors based on recent SEC 13F filings (Q1 2026). This page analyzes institutional buying and selling activity, new holdings, and sold-out positions among tracked filers. Notable filers include Renaissance Technologies LLC, Polen Capital Management, and Hancock Classic Value.

Portfolio quarterNameTypeQuantityRemainingReported stock balance
Q1 2026Renaissance Technologies LLCBuy31,435576,735$31,899,213
Q1 2026Polen Capital ManagementBuy6,7756,775$374,725
Q4 2025Renaissance Technologies LLCSell-9,900545,300$20,372,408
Q3 2025Renaissance Technologies LLCSell-55,600555,200$22,463,392
Q2 2025Renaissance Technologies LLCSell-94,500610,800$15,599,832
Q1 2025Hancock Classic ValueSell-578,950723,830$15,461,009
Q1 2025Renaissance Technologies LLCBuy147,500705,300$15,065,208
Q4 2024Hancock Classic ValueSell-158,0201,302,780$27,358,380
Q4 2024Renaissance Technologies LLCBuy10,600557,800$11,713,800
Q3 2024Hancock Classic ValueSell-376,2061,460,800$32,897,216
Q3 2024Renaissance Technologies LLCBuy20,400547,200$12,322,944
Q2 2024Hancock Classic ValueSell-131,1611,837,006$30,806,591
Q2 2024Renaissance Technologies LLCSell-200526,800$8,834,436
Q1 2024Renaissance Technologies LLCSell-47,600527,000$6,814
Q1 2024Hancock Classic ValueSell-21,3911,968,167$25,448,399
Q4 2023Hancock Classic ValueSell-79,4281,989,558$23,039,082
Q4 2023Renaissance Technologies LLCBuy47,900574,600$6,654
Q3 2023Hancock Classic ValueSell-1,5632,068,986$26,420,951
Q3 2023Renaissance Technologies LLCBuy1,200526,700$6,726
Q2 2023Hancock Classic ValueSell-94,6512,070,549$28,366,521
Q2 2023Renaissance Technologies LLCBuy1,500525,500$7,199
Q1 2023Hancock Classic ValueBuy195,9642,165,200$33,170,864
Q1 2023Renaissance Technologies LLCSell-7,700524,000$8,028
Q4 2022Hancock Classic ValueBuy47,5131,969,236$26,407,455
Q4 2022Renaissance Technologies LLCSell-9,800531,700$7,130
Q3 2022Renaissance Technologies LLCSell-59,400541,500$7,197
Q3 2022Hancock Classic ValueSell-14,7411,921,723$25,540
Q2 2022Hancock Classic ValueBuy355,6521,936,464$37,045
Q2 2022Renaissance Technologies LLCBuy1,800600,900$11,495
Q1 2022Hancock Classic ValueBuy173,1371,580,812$31,537

Frequently asked questions about PAHC activity

  • Which institutional owners are buying PAHC?

    Institutional owners buying PAHC include investors who have either initiated new positions or increased their existing holdings based on recent SEC 13F filings. The activity table above highlights which funds added shares in the latest reporting periods and how their positions changed over time.

  • What does "buy" mean in PAHC activity?

    "Buy" means an investor increased their reported position in PAHC compared to the prior reporting period. This reflects growing exposure to PHIBRO ANIMAL HEALTH CORP-A (PAHC) rather than necessarily a brand-new position (though new positions also appear as buys when prior quantity was zero).

  • Is institutional interest in PAHC increasing?

    Institutional interest in PAHC can be assessed by comparing the number of tracked funds adding or increasing positions versus those trimming or exiting across the periods shown. A higher number of additions typically signals increasing participation among large filers, but it should be read alongside position sizes and the full table.

Related PAHC insights